| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.033 | 0.9 |